An experimental pharmaceutical compound known as JQ1 blocks the region of BRDT responsible for chromatin remodeling, resulting in a temporary reduction of sperm production and quality; when tested in mice, the result was a cessation of male fertility that was reversed when use of JQ1 was discontinued.